Skip to main content

Mahon Paul A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Nov 13, 2025

Accession no.
0001231589-25-000010
Filed
Nov 13, 2025
Trade date
Nov 13, 2025
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.11M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mahon Paul ACIK 0001231589Officer (EVP & GENERAL COUNSEL)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseAcquired+11,000$135.42+$1,489,62047,781Direct
Nov 13, 2025Common StockSSaleDisposed−200$456.39−$91,27847,581Direct
Nov 13, 2025Common StockSSaleDisposed−1,063$458.16F2−$487,024.0846,518Direct
Nov 13, 2025Common StockSSaleDisposed−1,040$461.36F3−$479,814.445,478Direct
Nov 13, 2025Common StockSSaleDisposed−979$463.32F4−$453,590.2844,499Direct
Nov 13, 2025Common StockSSaleDisposed−1,979$464.19F5−$918,632.0142,520Direct
Nov 13, 2025Common StockSSaleDisposed−776$465.37F6−$361,127.1241,744Direct
Nov 13, 2025Common StockSSaleDisposed−884$466.24F7−$412,156.1640,860Direct
Nov 13, 2025Common StockSSaleDisposed−1,992$467.37F8−$931,001.0438,868Direct
Nov 13, 2025Common StockSSaleDisposed−2,070$468.48F9−$969,753.636,798Direct
Nov 13, 2025Common StockSSaleDisposed−17$469.09−$7,974.5336,781Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseDisposed−11,000$0.00$011,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $457.83 to $458.6475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $460.84 to $461.7675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $462.75 to $463.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $463.76 to $464.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $464.85 to $465.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $465.85 to $466.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $466.88 to $467.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $468.015 to $469.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)